z-logo
open-access-imgOpen Access
First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus
Author(s) -
Maryam Alkhatry,
Ahmad AlRifai,
Vito Annese,
F. Georgopoulos,
Ahmad Jazzar,
Ahmed M. Khassouan,
Zaher Koutoubi,
Rahul A. Nathwani,
Mazen Taha,
Jimmy K. Limdi
Publication year - 2020
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v26.i43.6710
Subject(s) - medicine , inflammatory bowel disease , ulcerative colitis , guideline , hepatology , disease , incidence (geometry) , delphi method , crohn's disease , consensus conference , expert opinion , intensive care medicine , psychological intervention , gastroenterology , pathology , statistics , physics , mathematics , psychiatry , optics
Ulcerative colitis and Crohn's disease are the main entities of inflammatory bowel disease characterized by chronic remittent inflammation of the gastrointestinal tract. The incidence and prevalence are on the rise worldwide, and the heterogeneity between patients and within individuals over time is striking. The progressive advance in our understanding of the etiopathogenesis coupled with an unprecedented increase in therapeutic options have changed the management towards evidence-based interventions by clinicians with patients. This guideline was stimulated and supported by the Emirates Gastroenterology and Hepatology Society following a systematic review and a Delphi consensus process that provided evidence- and expert opinion-based recommendations. Comprehensive up-to-date guidance is provided regarding diagnosis, evaluation of disease severity, appropriate and timely use of different investigations, choice of appropriate therapy for induction and remission phase according to disease severity, and management of main complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here